Bionano Genomics, Inc. (BNGO) Debt Components
- 2025-12-31: Debt Instrument, Repurchase AmountUSD $49.50M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Convertible Notes PayableUSD (m).
- 2025-09-30: Debt Instrument, Repurchase AmountUSD $49.50M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Convertible Notes PayableUSD (m).
- 2025-06-30: Debt Instrument, Repurchase AmountUSD $49.50M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Convertible Notes PayableUSD (m).
- 2025-03-31: Debt Instrument, Repurchase AmountUSD $49.50M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Convertible Notes PayableUSD (m).
Bionano Genomics, Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Debt Instrument, Repurchase Amount USD | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Convertible Notes Payable USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-term Debt, Gross USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed pure | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $49.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $49.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $49.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $49.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $49.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $49.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · 115.00% | (m) |
| 2024-06-30 | $49.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-05-01 | $20.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | $14.87M | (m) | $14.87M | (m) | (m) | (m) | (m) | (m) | $16.10M | (m) | (m) | $1.23M |
| 2020-12-31 | (m) | (m) | $16.32M | (m) | $16.33M | (m) | (m) | (m) | (m) | (m) | $17.76M | (m) | (m) | $1.43M |
| 2020-12-31 | (m) | $0.00 | (m) | (m) | (m) | $0.00 | $7.81M | $8.05M | $1.89M | $0.00 | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $14.24M | $1.77M | (m) | $16.01M | (m) | (m) | (m) | (m) | (m) | $17.64M | (m) | (m) | $1.62M |
| 2020-06-30 | (m) | $13.94M | $1.77M | (m) | $15.71M | (m) | (m) | (m) | (m) | (m) | $17.52M | (m) | (m) | $1.80M |
| 2020-03-31 | (m) | $16.97M | (m) | (m) | $16.97M | (m) | (m) | (m) | (m) | (m) | $18.62M | (m) | (m) | $1.66M |
| 2019-12-31 | (m) | $20.08M | $0.00 | (m) | $20.08M | (m) | (m) | (m) | (m) | (m) | $21.97M | (m) | (m) | $1.89M |
| 2019-12-31 | (m) | (m) | (m) | $0.00 | (m) | $5.00M | $0.00 | $5.44M | $7.93M | $2.11M | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | $18.78M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | $18.62M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | $18.38M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $0.00 | $9.03M | (m) | $9.03M | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | $970.63K |
| 2018-12-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $0.00 | $9.01M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $6.73M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-08 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3.25% | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |